relation: http://eprints.unpak.ac.id/7473/
title: BLOOD PRESSURE CONTROL   PROFILE AND COST-EFFECTIVENESS ANALYSIS (CEA) OF   AMLODIPINE AND RAMIPRIL DRUGS IN HYPERTENSIVE PATIENTS   AT SUMEDANG REGIONAL GENERAL HOSPITAL. Under the guidance
creator: Rahayu, Dian Fitri
creator: Rokhmah, Nisa Najwa
creator: Elfrieda, NSA Lily
subject: Farmasi
description: DIAN FITRI RAHAYU. 066119154. 2023. BLOOD PRESSURE CONTROL   PROFILE AND COST-EFFECTIVENESS ANALYSIS (CEA) OF   AMLODIPINE AND RAMIPRIL DRUGS IN HYPERTENSIVE PATIENTS   AT SUMEDANG REGIONAL GENERAL HOSPITAL. Under the guidance   of Nisa Najwa Rokhmah and Nyayu Siti Aminah Lily Elfrieda.  Hypertension is a degenerative disease that has a high risk that requires   long-term treatment. The choice of drug use for patients diagnosed with   hypertension, hospital treatment and the increasing number of doctor visits, have   an impact on the high cost of treatment. This is what must be considered from an   economic perspective in selecting drugs that are affordable and provide good   therapeutic effects.  This study aims to assess the picture of blood pressure control and analyze   the most cost-effective therapeutic drugs from the use of Amlodipine and   Ramipril in outpatient hypertension patients at the Sumedang Regional General   Hospital. This research is a non-experimental study with a retrospective study of   outpatient medical record data and administration in pharmacy installations. The   parameters used are blood pressure and drug costs.  The results of the study showed that antihypertensive blood pressure   control using Amlodipine 5mg was 28% and Amlodipine 10mg was 44% higher   compared to patients using Ramipril 5mg by 8% and Ramipril 10mg by 20%. The   most cost-effective use of antihypertensives in hypertensive patients is   Amlodipine with an ACER value of Amlodipine 5 mg Rp. 190.89 and   Amlodipine 10 mg Rp. 172.36. And obtained an ICER value of Rp. -27.4 and Rp.   -44.4 with a comparison of Ramipril 5mg and Ramipril 10mg. From these results,   it can be concluded that the use of amlodipine produces better controlled blood   pressure and is more cost-effective than Ramipril.  Keywords: antihypertensive, cost-effectiveness, hypertension
date: 2024-01-02
type: Thesis
type: NonPeerReviewed
format: text
language: en
identifier: http://eprints.unpak.ac.id/7473/1/FINALLY%20.pdf
identifier:   Rahayu, Dian Fitri and Rokhmah, Nisa Najwa and Elfrieda, NSA Lily  (2024) BLOOD PRESSURE CONTROL PROFILE AND COST-EFFECTIVENESS ANALYSIS (CEA) OF AMLODIPINE AND RAMIPRIL DRUGS IN HYPERTENSIVE PATIENTS AT SUMEDANG REGIONAL GENERAL HOSPITAL. Under the guidance.  Skripsi thesis, Universitas Pakuan.